Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7950 results

Sort By:

Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

Study ID: NCT04270591
Start Date: 2019-07-15
End Date: 2023-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

183

Intervention / Treatment

Glumetinib

Sponsor

Haihe biopharma co., ltd.

Source: clinicaltrials.gov

Share:
Add to list

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

Study ID: NCT05226494
Start Date: 2022-06-23
End Date: 2025-10-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

34

Intervention / Treatment

fb-PMT

Sponsor

NanoPharmaceuticals LLC

Source: clinicaltrials.gov

Share:
Add to list

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

Study ID: NCT05833360
Start Date: 2023-07-14
End Date: 2030-07-14
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2400

Intervention / Treatment

Exai oncRNA blood test

Sponsor

Exai Bio Inc.

Source: clinicaltrials.gov

Share:
Add to list

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts W/Chronic Myeloid Leukemia

Study ID: NCT06229860
Start Date: 2024-01-25
End Date: 2026-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

Interview

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

Glioblastoma Remote Monitoring and Care - Research Protocol

Study ID: NCT06129760
Start Date: 2024-04-30
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Apple Watch

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Study ID: NCT05428176
Start Date: 2023-02-16
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

332

Intervention / Treatment

Best Practice

Internet-Based Intervention

Quality-of-Life Assessment

Administration questionnaire

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Study ID: NCT06838676
Start Date: 2025-07
End Date: 2035-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

ACT001

Sponsor

Nationwide Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Study ID: NCT05604560
Start Date: 2023-11-08
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Tiskelizumab

SX-682

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Pre-malignant States to Hematologic Malignancies in Firefighters

Study ID: NCT06870760
Start Date: 2025-06
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Monoclonal Gammopathy

Complete Blood Count with differential (CBC w/ diff)

Clonal hematopoiesis (CHIP)

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Study ID: NCT03520491
Start Date: 2018-04-25
End Date: 2026-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Nivolumab

Ipilimumab

Radical cystectomy

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list